Catalyst Wire Dossier Catalyst Wire Dossier

Rezulin

Troglitazone · Parke-Davis
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Rezulin, covering 2009-12-11 to 2009-12-11. Get the full timeline:

Most recent: Clinical Trial Update: TART - Troglitazone Atherosclerosis Regression Trial [Phase 2, Phase 3]

See pricing